Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.
about
Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumoursPreliminary results from a crowdsourcing experiment in immunohistochemistryCrowdsourcing scoring of immunohistochemistry images: Evaluating Performance of the Crowd and an Automated Computational MethodNew Robust and Reproducible Stereological IHC Ki67 Breast Cancer Proliferative Assessment to Replace Traditional Biased Labeling Index.Automated analysis of co-localized protein expression in histologic sections of prostate cancer.A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissueAn Advanced Deep Learning Approach for Ki-67 Stained Hotspot Detection and Proliferation Rate Scoring for Prognostic Evaluation of Breast Cancer.A novel model for Ki67 assessment in breast cancer.The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancerThe relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancerMacroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures.A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancerComparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.Quantum dots-based double imaging combined with organic dye imaging to establish an automatic computerized method for cancer Ki67 measurementMir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancerInterobserver Variability of Ki-67 Measurement in Breast Cancer.High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association ConsortiumThe relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.The in situ local immune response, tumour senescence and proliferation in colorectal cancer.Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancerPrognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.Semi-automated evaluation of Ki-67 index in invasive ductal carcinoma of the breast.Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort studyKi67 and proliferation in breast cancer.High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer.The use of digital images improves reproducibility of the ki-67 labeling index as a proliferation marker in breast cancer.Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma.Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer.Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.External validation of the ImmunoRatio image analysis application for ERα determination in breast cancer.Prognostic value of ki-67 in breast carcinoma: tissue microarray method versus whole section analysis- potentials and pitfalls.Experimental study on the clinical effects of Xiaoru Sanjie Jiaonang on mammary glands hyperplasia and ki-67.An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications.Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer.Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment
P2860
Q28364789-FCEA3DD7-9813-43DB-A86D-A14901AD2491Q28651551-DA161DFE-69EF-4B85-8A57-CDF4AAA76B88Q30362485-0A61294A-1316-4900-A1E2-232AD1FA992DQ30489246-E626926C-1C68-40A4-82E9-4F071BABB872Q33732080-9CA51385-FB3D-41EF-9F4D-1DF3DB679ABBQ33739487-F174E906-2ABD-4B9C-8F51-3F5993C99ED4Q33789933-88E42F0F-24DB-427F-BC39-73C6AD86F51CQ33801255-23C6A6B8-D673-4D16-A655-F745FC367215Q33877484-7475E780-A57B-452E-904B-C2D38B4A867AQ34245787-3D2071AB-38B8-4C40-9C2B-00D519F7610EQ35806203-9926CB03-72D6-49C6-8072-561C6A0E7BD6Q35940233-8B554D73-18A5-4658-8C4C-663D40A19F56Q36186338-32538727-2D25-467A-B73D-0A07DEAEB1EEQ36279137-019B0EE6-586B-4BC0-A14B-D680327ABCF9Q36295039-DC9C028D-ADC0-4A3E-BDBF-1DE9BCDE0617Q36536487-5818B408-7F45-417D-A419-5CCA29844068Q36557814-E7246C17-B511-4276-8FCC-5E8EF4410E19Q36719073-C55B1D79-233D-410B-813A-9C6D77607B8AQ37121271-2FF3BF77-2D13-4B49-B6DA-5270B3D40D90Q37182278-802FF2E9-2B37-4CA4-9EB9-292C7CEDA0E2Q37235543-16CE0C30-0EAD-47CA-AAC5-EFBB087FB7F6Q37278408-96A21145-61DB-46CB-80C1-C7316D4DA463Q37350137-FE11BE8F-B1DB-45EA-9DAD-3CDE09B0332DQ37388652-33C4C768-286D-4430-B1CC-16C11BB378ACQ37548507-FE07A0C7-7B29-49E9-9727-15E5738A03CEQ38084286-13F0413A-6EDA-4731-944E-DDD9C1C4AC7CQ38724755-6060F1C5-A7EE-451E-9228-3AB6698B3BADQ40148453-BC0D3735-67D4-465A-9DEC-1C05057DD189Q40217601-19819B57-CB49-420D-8AF7-FF5B051D5C68Q40362934-BCF6F9E5-7240-4E13-930C-2FE1E0C6B105Q40454863-94BF8124-F95C-43B5-9D98-6F17D4B83585Q40626929-5D191D9A-4249-4F74-B0F6-4AE8C5667860Q44966169-23BA9B22-582F-47FF-B290-D34A3C0021F6Q47205521-EA09B372-35D6-4CB9-AD84-B3EAC642C29DQ47678046-A400AAA9-2CF2-429A-B011-48A49A5E3698Q51122740-DCE6617A-7E43-4F07-BA1B-31C3AEF33F08Q52720152-8E4B532C-41CB-44E3-A337-3C8A8F59BE6BQ53111508-26C98D5A-1F0F-412A-A98E-F9C29F4C7A8BQ53555841-4C8409EF-A693-4E14-B175-C51648D6FFF8Q58698990-3215AFB7-7C0D-46F7-AE25-0E7C447734D4
P2860
Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Comparison of visual and autom ...... invasive ductal breast cancer.
@ast
Comparison of visual and autom ...... invasive ductal breast cancer.
@en
type
label
Comparison of visual and autom ...... invasive ductal breast cancer.
@ast
Comparison of visual and autom ...... invasive ductal breast cancer.
@en
prefLabel
Comparison of visual and autom ...... invasive ductal breast cancer.
@ast
Comparison of visual and autom ...... invasive ductal breast cancer.
@en
P2093
P2860
P356
P1476
Comparison of visual and autom ...... invasive ductal breast cancer.
@en
P2093
B Elsberger
D C McMillan
J C Doughty
Z M A Mohammed
P2860
P2888
P304
P356
10.1038/BJC.2011.569
P407
P577
2012-01-03T00:00:00Z